Dr. Johannes Notni studied and graduated in chemistry at the University of Jena (Thuringia). After receiving his doctoral degree, he moved to the venerable Charles University in Prague, where he started developing the TRAP technology which now powers innovation at TRIMT GmbH. He continued his academic career at Technical University of Munich for more than a decade, where he developed innovative molecular probes. In 2021, he accepted a position as university professor for experimental radiopharmacy at Universitätsklinikum Essen. In light of the thriving performance of TRIMT, he recently took a full-time position as Chief Science Officer. He now manages and drives the company’s technological advancement towards a better diagnosis and cure of the most dreadful cancers.